AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-component extract (timothy major allergens Nos. 19 and 25)
Number of subjects: 100
Study 7181051 — intervention group
Group type: COMPARATOR
Intervention: 20-component timothy extract
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-component extract
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: High single dose (greater than or equal to 1,000 biological units)
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: High nasal sensitivity before treatment
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate local skin reactions (greater than or equal to 2 cm)
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed local side effects (greater than or equal to 10 cm)
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed local side effects
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetition of a single dose
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses (greater than or equal to 5,000 biological units)
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial preseasonal therapy
Number of subjects: 100
Study 7181051 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent perennial dosage
Number of subjects: 100
Study 30340060 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient plus partner (P+P)
Number of subjects: 301
Study 27215634 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity aerobic training (55% V˙O2 peak)
Number of subjects: 12
Study 27215634 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity aerobic training (75% V˙O2 peak)
Number of subjects: 12
Study 25534777 — intervention group
Group type: EXPERIMENTAL
Intervention: Operant Conditioning (OC)
Number of subjects: 68
Study 25534777 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic Desensitization (SysD)
Number of subjects: 68
Study 25534777 — intervention group
Group type: COMPARATOR
Intervention: Combined data from OC and SysD
Number of subjects: 68
Study 24346489 — intervention group
Group type: EXPERIMENTAL
Intervention: Young women (45 years or younger)
Number of subjects: 243
Study 24346489 — intervention group
Group type: EXPERIMENTAL
Intervention: Older women (65 years or older)
Number of subjects: 243
Study 24346489 — intervention group
Group type: COMPARATOR
Intervention: All age groups
Number of subjects: 243
Study 22563189 — intervention group
Group type: EXPERIMENTAL
Intervention: AHM (0.15 gm/d) for 12 weeks
Number of subjects: 40
Study 22563189 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch) for 12 weeks
Number of subjects: 40
Study 19760309 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation followed by surgery
Number of subjects: 0
Study 19760309 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study 17275158 — intervention group
Group type: EXPERIMENTAL
Intervention: Skillreporter manikin (continuous feedback)
Number of subjects: 98
Study 17275158 — intervention group
Group type: COMPARATOR
Intervention: Conventional manikin (instructor feedback)
Number of subjects: 98
Study 15184222 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic detailing and parental education program
Number of subjects: 11
Study 15184222 — intervention group
Group type: COMPARATOR
Intervention: Practice-specific report cards
Number of subjects: 11
Study 15184222 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 11
Study 15184222 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporins
Number of subjects: 11
Study 11435293 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonleukoreduced RBCs
Number of subjects: 93
Study 11435293 — intervention group
Group type: COMPARATOR
Intervention: Leukoreduced RBCs
Number of subjects: 93
Study 10396521 — intervention group
Group type: EXPERIMENTAL
Intervention: Interview administration of questionnaire
Number of subjects: 431
Study 10396521 — intervention group
Group type: COMPARATOR
Intervention: Postal administration of questionnaire
Number of subjects: 431
Study 8041988 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly chemotherapy with 7 active drugs (cyclophosphamide + adriamycin + etoposide on day 1; cisplatin + vindesine on day 8; methotrexate + vincristine on day 15)
Number of subjects: 215
Study 8041988 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (cyclophosphamide + adriamycin + etoposide given at the cycle beginning)
Number of subjects: 215
Study 2011707 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehydration of faecal occult blood tests
Number of subjects: 0
Study 2011707 — intervention group
Group type: COMPARATOR
Intervention: Non-rehydration of faecal occult blood tests
Number of subjects: 0
Study 6787557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent gastric gavage feedings
Number of subjects: 53
Study 6787557 — intervention group
Group type: COMPARATOR
Intervention: Transpyloric (nasojejunal) feedings
Number of subjects: 53
Study 30470465 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 401
Study 30470465 — intervention group
Group type: COMPARATOR
Intervention: Regional Anesthesia (RA)
Number of subjects: 401
Study 28392859 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 55
Study 28392859 — intervention group
Group type: COMPARATOR
Intervention: Conventional training group (CTG)
Number of subjects: 55
Study 26866770 — intervention group
Group type: EXPERIMENTAL
Intervention: SMR neurofeedback training (SMR NFT)
Number of subjects: 16
Study 26866770 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 23360662 — intervention group
Group type: EXPERIMENTAL
Intervention: escitalopram (ESC)+bupropion (BUP)
Number of subjects: 51
Study 23360662 — intervention group
Group type: EXPERIMENTAL
Intervention: escitalopram (ESC)
Number of subjects: 51
Study 23360662 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion (BUP)
Number of subjects: 51
Study 23360662 — intervention group
Group type: EXPERIMENTAL
Intervention: N1 sLORETA-LDAEP
Number of subjects: 51
Study 21254797 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (100 mg)
Number of subjects: 28
Study 21254797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 19616204 — intervention group
Group type: EXPERIMENTAL
Intervention: Inanimate simulator training (6 hours)
Number of subjects: 17
Study 19616204 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual simulator training (4 hours with LapSim)
Number of subjects: 17
Study 19616204 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 17
Study 17535634 — intervention group
Group type: EXPERIMENTAL
Intervention: SGD group (100 mg Tobramycin, 40 mg garlicin, and 20% Lactulose for 10 ml three times per day for 3 days)
Number of subjects: 30
Study 17535634 — intervention group
Group type: COMPARATOR
Intervention: Control group (preoperative bowel preparation: diet preparation and enema)
Number of subjects: 30
Study 15194029 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Number of subjects: 61
Study 15194029 — intervention group
Group type: COMPARATOR
Intervention: Control (no hyperbaric oxygen therapy)
Number of subjects: 61
Study 11277584 — intervention group
Group type: EXPERIMENTAL
Intervention: Nociceptive nerve terminals in neuropathic patients
Number of subjects: 90
Study 11277584 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 90
Study 11277584 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropathic patients
Number of subjects: 90
Study 9797906 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (25 micrograms/day for 8 weeks)
Number of subjects: 116
Study 9797906 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (250 micrograms/day for 8 weeks)
Number of subjects: 116
Study 9797906 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (1250 micrograms/day for 8 weeks)
Number of subjects: 116
Study 9797906 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D3 (10 micrograms/day for 4 weeks)
Number of subjects: 116
Study 9797906 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D3 (20 micrograms/day for 4 weeks)
Number of subjects: 116
Study 9797906 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D3 (50 micrograms/day for 4 weeks)
Number of subjects: 116
Study 9797906 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D3 (0.5 microgram/day for 2 weeks)
Number of subjects: 116
Study 9797906 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D3 (1.0 microgram/day for 2 weeks)
Number of subjects: 116
Study 8056008 — intervention group
Group type: EXPERIMENTAL
Intervention: Elgodipine 20 mg
Number of subjects: 12
Study 8056008 — intervention group
Group type: EXPERIMENTAL
Intervention: Elgodipine 40 mg
Number of subjects: 12
Study 8056008 — intervention group
Group type: EXPERIMENTAL
Intervention: Elgodipine 60 mg
Number of subjects: 12
Study 8056008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3060024 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin to skin contact (35 infants)
Number of subjects: 71
Study 3060024 — intervention group
Group type: COMPARATOR
Intervention: Control group (36 infants)
Number of subjects: 71
Study 31397129 — intervention group
Group type: EXPERIMENTAL
Intervention: Grain-moxibustion combined with medicine therapy (vitamin E capsules and Wuzi Yanzong pills)
Number of subjects: 60
Study 31397129 — intervention group
Group type: COMPARATOR
Intervention: Control group (vitamin E capsules and Wuzi Yanzong pills)
Number of subjects: 60
Study 31397129 — intervention group
Group type: EXPERIMENTAL
Intervention: Grain-moxibustion combined with medicine therapy
Number of subjects: 60
Study 27940180 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle weight loss (LWL) intervention delivered by community health workers
Number of subjects: 260
Study 27940180 — intervention group
Group type: COMPARATOR
Intervention: Diabetes self-management (DSM) education condition
Number of subjects: 260
Study 25088520 — intervention group
Group type: EXPERIMENTAL
Intervention: structured dietary treatment
Number of subjects: 68
Study 25088520 — intervention group
Group type: EXPERIMENTAL
Intervention: physical exercise treatment
Number of subjects: 68
Study 25088520 — intervention group
Group type: EXPERIMENTAL
Intervention: combined treatment
Number of subjects: 68
Study 25088520 — intervention group
Group type: COMPARATOR
Intervention: usual care (controls)
Number of subjects: 68
Study 23562754 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid therapy (40 mg omeprazole and 1 g amoxicillin, twice daily for 14 days; 500 mg clarithromycin and 500 mg nitroimidazole added, twice daily for the final 7 days)
Number of subjects: 343
Study 23562754 — intervention group
Group type: COMPARATOR
Intervention: Concomitant therapy (same 4 drugs taken concurrently, twice daily for 14 days)
Number of subjects: 343
Study 23562754 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid therapy
Number of subjects: 343
Study 23562754 — intervention group
Group type: COMPARATOR
Intervention: Concomitant therapy
Number of subjects: 343
Study 23562754 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 343
Study 21840720 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified techniques of Bryan cervical disc arthroplasty
Number of subjects: 49
Study 21840720 — intervention group
Group type: COMPARATOR
Intervention: Standard techniques of Bryan cervical disc arthroplasty
Number of subjects: 49
Study 17700582 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHImage
Number of subjects: 15
Study 17700582 — intervention group
Group type: EXPERIMENTAL
Intervention: SliceOmatic
Number of subjects: 15
Study 17700582 — intervention group
Group type: EXPERIMENTAL
Intervention: Analyze
Number of subjects: 15
Study 17700582 — intervention group
Group type: EXPERIMENTAL
Intervention: HippoFat
Number of subjects: 15
Study 17700582 — intervention group
Group type: EXPERIMENTAL
Intervention: EasyVision
Number of subjects: 15
Study 17700582 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully automated program
Number of subjects: 15
Study 17700582 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-automated approaches
Number of subjects: 15
Study 17700582 — intervention group
Group type: EXPERIMENTAL
Intervention: VAT measurements
Number of subjects: 15
Study 17700582 — intervention group
Group type: EXPERIMENTAL
Intervention: SAT and CSA measurements
Number of subjects: 15
Study 16280230 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Tests of Information Processing (CTIP) - includes Simple RT, Choice RT, and Semantic Search RT
Number of subjects: 4
Study 16280230 — intervention group
Group type: COMPARATOR
Intervention: Control group (cognitively‐intact individuals)
Number of subjects: 4
Study 16280230 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild TBI group
Number of subjects: 4
Study 16280230 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe TBI group
Number of subjects: 4
Study 15128184 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate stress test using Acutrend Lactate (LST2)
Number of subjects: 63
Study 15128184 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate stress test using Ektachrome Clinical Chemistry Slide (LST1)
Number of subjects: 63
Study 15128184 — intervention group
Group type: COMPARATOR
Intervention: Comparison of LST1 and LST2
Number of subjects: 63
Study 11121928 — intervention group
Group type: EXPERIMENTAL
Intervention: CSEcure(R) (SIMS Portex, UK) locking needle
Number of subjects: 200
Study 11121928 — intervention group
Group type: COMPARATOR
Intervention: Conventional, non-locking technique
Number of subjects: 200
Study 8639239 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-bonded fixed partial dentures with high noble alloy inlay retainers and a metal ceramic pontic (51 total dentures)
Number of subjects: 39
Study 8639239 — intervention group
Group type: COMPARATOR
Intervention: Tin-plated fixed partial dentures (14 total dentures)
Number of subjects: 39
Study 1410160 — intervention group
Group type: EXPERIMENTAL
Intervention: High-nicotine cigarette
Number of subjects: 22
Study 1410160 — intervention group
Group type: COMPARATOR
Intervention: Ultralow-nicotine cigarette
Number of subjects: 22
Study 1410160 — intervention group
Group type: COMPARATOR
Intervention: Medium-nicotine cigarette
Number of subjects: 22
Study 1410160 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma nicotine levels
Number of subjects: 22
Study 3935377 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg fluvoxamine as a single daytime dose
Number of subjects: 62
Study 3935377 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg fluvoxamine as a single night-time dose
Number of subjects: 62
Study 3935377 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg fluvoxamine twice daily
Number of subjects: 62
Study 3935377 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 week wash-out period)
Number of subjects: 62
Study 30148993 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture pulley ESD
Number of subjects: 13
Study 30148993 — intervention group
Group type: COMPARATOR
Intervention: Traditional ESD
Number of subjects: 13
Study 29720146 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily SMS reminders in addition to usual treatment
Number of subjects: 279
Study 29720146 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment only
Number of subjects: 279
Study 27558186 — intervention group
Group type: EXPERIMENTAL
Intervention: Androstenedione (300 mg for 7 days)
Number of subjects: 11
Study 27558186 — intervention group
Group type: COMPARATOR
Intervention: Cellulose placebo (control)
Number of subjects: 11
Study 24831252 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal mask
Number of subjects: 21
Study 24831252 — intervention group
Group type: COMPARATOR
Intervention: Oronasal mask
Number of subjects: 21
Study 22536983 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training for 16 weeks
Number of subjects: 30
Study 22536983 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 30
Study 22536983 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 30
Study 20602723 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Migraine (CM)
Number of subjects: 300
Study 20602723 — intervention group
Group type: COMPARATOR
Intervention: Episodic Migraine (EM)
Number of subjects: 300
Study 20602723 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CM and EM
Number of subjects: 300
Study 17722965 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitazoxanide
Number of subjects: 0
Study 16220865 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 3204
Study 16220865 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccination
Number of subjects: 3204
Study 16220865 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 3204
Study 12118965 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B
Number of subjects: 81
Study 12118965 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B
Number of subjects: 81
Study 9987544 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cardiac output measurement
Number of subjects: 60
Study 9987544 — intervention group
Group type: COMPARATOR
Intervention: Bolus cardiac output measurement
Number of subjects: 60
Study 8560587 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (two different dosages)
Number of subjects: 0
Study 8560587 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated)
Number of subjects: 0
Study 2125681 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (recombinant tissue-type plasminogen activator, t-PA)
Number of subjects: 12490
Study 2125681 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase (SK)
Number of subjects: 12490
Study 2125681 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase (SK) with heparin
Number of subjects: 12490
Study 2125681 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (t-PA) with or without heparin
Number of subjects: 12490
Study 2125681 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (t-PA)
Number of subjects: 12490
Study 6108123 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 40 mg
Number of subjects: 12
Study 6108123 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 12
Study 6108123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30778546 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM)
Number of subjects: 6661
Study 30778546 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of acupuncture and herbal medicine
Number of subjects: 6661
Study 27416886 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital Readmissions Reduction Program (HRRP)
Number of subjects: 0
Study 27416886 — intervention group
Group type: COMPARATOR
Intervention: Comparison group of patients treated at hospitals with readmission rates below or equal to the national average (not at risk)
Number of subjects: 0
Study 25870325 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF/FTC
Number of subjects: 46
Study 25870325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 23467207 — intervention group
Group type: EXPERIMENTAL
Intervention: L-citrulline (100mg/kg)
Number of subjects: 16
Study 23467207 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Maltodextrin)
Number of subjects: 16
Study 21502796 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg tid) with normo-caloric diet
Number of subjects: 20
Study 21502796 — intervention group
Group type: COMPARATOR
Intervention: Normo-caloric diet without orlistat
Number of subjects: 20
Study 19156832 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet adhesive
Number of subjects: 12
Study 19156832 — intervention group
Group type: COMPARATOR
Intervention: Control (no autologous platelet adhesive)
Number of subjects: 12
Study 17870038 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (500 mg elemental calcium daily for 12 months)
Number of subjects: 86
Study 17870038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 17870038 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 86
Study 17870038 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation and placebo
Number of subjects: 86
Study 15370943 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (200 mg/day)
Number of subjects: 100
Study 15370943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 11078484 — intervention group
Group type: EXPERIMENTAL
Intervention: MCC-CRM(197)
Number of subjects: 226
Study 11078484 — intervention group
Group type: EXPERIMENTAL
Intervention: MCC-TT
Number of subjects: 226
Study 11078484 — intervention group
Group type: EXPERIMENTAL
Intervention: MCC-CRM(197) and MCC-TT
Number of subjects: 226
Study 11078484 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysaccharide booster
Number of subjects: 226
Study 9681390 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF‐alpha
Number of subjects: 66
Study 9681390 — intervention group
Group type: EXPERIMENTAL
Intervention: sTNF‐R p55
Number of subjects: 66
Study 9681390 — intervention group
Group type: EXPERIMENTAL
Intervention: sTNF‐R p75
Number of subjects: 66
Study 9681390 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF‐beta
Number of subjects: 66
Study 9681390 — intervention group
Group type: COMPARATOR
Intervention: Control group (14 healthy subjects)
Number of subjects: 66
Study 7924480 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal nasal continuous positive airway pressure (CPAP)
Number of subjects: 8
Study 7924480 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (not specified)
Number of subjects: 8
Study 2924091 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resolution computed tomography (CT)
Number of subjects: 62
Study 2924091 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiology
Number of subjects: 62
Study 60988 — intervention group
Group type: EXPERIMENTAL
Intervention: RNAse
Number of subjects: 507